Investigating how a tuberculosis bacteria enzyme interacts with host proteins
Function of a novel Mycobacterium tuberculosis lipase and its interaction with host proteins
This study is looking at how a special enzyme made by the bacteria that cause tuberculosis helps them survive in our bodies, with the goal of finding new ways to treat the infection.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10686799 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a specific enzyme produced by the tuberculosis-causing bacteria, Mycobacterium tuberculosis, and how it interacts with proteins in human cells. The researchers aim to uncover the mechanisms by which this enzyme helps the bacteria survive and thrive within the host. By studying these interactions, they hope to identify potential targets for new treatments that could disrupt the bacteria's ability to persist in the body. The approach includes laboratory techniques such as enzyme assays and protein interaction studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with tuberculosis or those at high risk of infection.
Not a fit: Patients with non-tuberculosis related infections or conditions will likely not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating tuberculosis more effectively.
How similar studies have performed: Other research has shown promise in targeting bacterial enzymes for therapeutic intervention, suggesting that this approach could be effective.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Kong, Ying — University of Tennessee Health Sci Ctr
- Study coordinator: Kong, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.